Abstract:Recent advances in molecular electrophysiology have made possible the development of more selective ion channel blockers for therapeutic use. However, more information is needed about the effects of blocking specific channels on repolarization in normal human atrium and in atrial cells of patients with atrial fibrillation (AF). AF-induced electrical remodeling is associated with reductions in transient outward current (Ito), ultrarapid delayed rectifier current (IKur), and L-type calcium current (ICa,L). Direct evaluation of the results of ion channel depression is limited by the nonspecificity of the available pharmacological probes.OBJECTIVES: Using a mathematical model of the human atrial action potential (AP), we aimed to: (1) evaluate the role of ionic abnormalities in producing AP changes characteristic of AF in humans and (2) explore the effects of specific channel blockade on the normal and AF-modified AP (AFAP).METHODS: We used our previously developed mathematical model of the normal human atrial AP (NAP) based on directly measured currents. We constructed a model of the AFAP by incorporating experimentally-measured reductions in Ito (50%), IKur (50%), and ICa,L (70%) current densities observed in AF.RESULTS: The AFAP exhibits the reductions in AP duration (APD) and rate-adaption typical of AF. The reduction in ICa,L alone can account for most of the morphological features of the AFAP. Inhibition of Ito by 90% leads to a reduction in APD measured at -60 mV in both the NAP and AFAP. Inhibition of the rapid component of the delayed rectifier (IKr) by 90% slows terminal repolarization of the NAP and AFAP and increases APD by 38% and 34%, respectively. Inhibition of IKur by 90% slows early repolarization and increases plateau height, activating additional IK and causing no net change in APD at 1 Hz in the NAP. In the presence of AF-induced ionic modifications, IKur inhibition increases APD by 12%. Combining IKur and IKr inhibition under both normal and AF conditions synergistically increases APD. In the NAP, altering the model parameters to reproduce other typical measured AP morphologies can significantly alter the response to K(+)-channel inhibition.CONCLUSIONS: (1) The described abnormalities in Ito, IKur and ICa,L in AF patients can account for the effects of AF on human AP properties; (2) AP prolongation by IKur block is limited by increases in plateau height that activate more IK; (3) Blockers of IKur may be more effective in prolonging APD in patients with AF; 4) Inhibition of both IKur and IKr produces supra-additive effects on APD. These observations illustrate the importance of secondary current alterations in the response of the AP to single channel blockade, and have potentially important implications for the development of improved antiarrhythmic drug therapy for AF.

2-Aminoethoxydiphenyl Borate, a Inositol 1,4,5-Triphosphate Receptor Inhibitor, Prevents Atrial Fibrillation

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

The Research of Inositol 1,4,5-Triphosphate Receptor and Cardiovascular Disease

2-Aminoethoxydiphenyl borate prolongs atrial and shortens ventricular action potential duration through modulation of ion channels in the sarcolemma

Enhanced Activity Of Inositol-1,4,5-Trisphosphate Receptors In Atrial Myocytes Of Atrial Fibrillation Patients

Inositol Trisphosphate Receptors and Nuclear Calcium in Atrial Fibrillation

Arnebiae Radix Prevents Atrial Fibrillation in Rats by Ameliorating Atrial Remodeling and Cardiac Function

Effects of a novel class III antiarrhythmic agent, CPUY11018, on rat atrial fibrillation

Inhibition of Mitochondrial Translocator Protein Prevents Atrial Fibrillation

Activation of IP3R in atrial cardiomyocytes leads to generation of cytosolic cAMP

In Vivo and In Vitro Antiarrhythmic Effects of SSR149744C in Animal Models of Atrial Fibrillation and Ventricular Arrhythmias

Evaluation of Anti-atrial Fibrillation Drug With Multi Ion Channel Targets by Micro-electrode Chip Technology in Experimental Rabbit Model

Inhibitory effect of aloperine on transient outward potassium currents in rat cardiac myocytes

Effect of Berberine on Acetylcholine-Induced Atrial Fibrillation in Rabbit.

Electrophysiological characterization and antiarrhythmic efficacy of the mixed potassium channel-blocking antiarrhythmic agent AZ13395438 in vitro and in vivo

The expression of IP3R1 and IP3R2 in atrial myocytes during atrial fibrillation in dogs

Inhibition of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in Rats with Anxiety Disorders

Inositol-1,4,5-Trisphosphate and Ryanodine-Dependent Ca2+ Signaling in A Chronic Dog Model of Atrial Fibrillation

PDE8 Inhibition and Its Impact on ICa,L in Persistent Atrial Fibrillation: Evaluation of PDE8 as a Potential Drug Target

[Expression and Function Changes of Ryanodine Receptors and Inositol 1,4,5-Triphosphate Receptors of Atrial Myocytes During Atrial Fibrillation].

Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model